Lyudmila Bazhenova, M.d.

This early-stage study tested the safety of combining an experimental drug, plinabulin, with an approved immunotherapy, nivolumab, for people with advanced non-small cell lung cancer that had spread. The main goal was to find the highest dose of the combination that patients coul…